{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:14:16Z","timestamp":1791476056567,"version":"4.3.4"},"reference-count":88,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Fungal infections are a significant global health challenge, causing approximately 3.8 million deaths annually, with immunocompromised populations particularly at risk. Traditional antifungal therapies, including azoles, echinocandins, and polyenes, face limitations due to rising antifungal resistance, toxicity, and inadequate treatment options. This review explores innovative strategies for preventing and managing fungal infections, such as vaccines, antifungal peptides, nanotechnology, probiotics, and immunotherapy. Vaccines offer promising avenues for long-term protection, despite difficulties in their development due to fungal complexity and immune evasion mechanisms. Antifungal peptides provide a novel class of agents with broad-spectrum activity and reduced resistance risk, whilst nanotechnology enables targeted, effective drug delivery systems. Probiotics show potential in preventing fungal infections, particularly vulvovaginal candidiasis, by maintaining microbial balance. Immunotherapy leverages immune system modulation to enhance antifungal defenses, and omics technologies deliver comprehensive insights into fungal biology, paving the way for novel therapeutic and vaccine targets. While these approaches hold immense promise, challenges such as cost, accessibility, and translational barriers remain. A coordinated effort among researchers, clinicians, and policymakers is critical to advancing these strategies and addressing the global burden of fungal infections effectively.<\/jats:p>","DOI":"10.3390\/pathogens14020126","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T04:36:51Z","timestamp":1738557411000},"page":"126","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Novel Strategies for Preventing Fungal Infections\u2014Outline"],"prefix":"10.3390","volume":"14","author":[{"given":"Damilola J.","family":"Agbadamashi","sequence":"first","affiliation":[{"name":"Institute of Life Science, Swansea University Medical School, Swansea SA2 8PP, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6045-4835","authenticated-orcid":false,"given":"Claire L.","family":"Price","sequence":"additional","affiliation":[{"name":"Institute of Life Science, Swansea University Medical School, Swansea SA2 8PP, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1016\/S1473-3099(23)00692-8","article-title":"Global incidence and mortality of severe fungal disease","volume":"24","author":"Denning","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Aranda-Audelo, M., Rivera-Mart\u00ednez, N.E., and Corzo-Le\u00f3n, D.E. (2018). Characteristics of Invasive Fungal Infections among HIV Individuals from an Indigenous Origin in Mexico. J. Fungi, 4.","DOI":"10.3390\/jof4030109"},{"key":"ref_3","first-page":"747","article-title":"Role of Fungal Infections in Carcinogenesis and Cancer Development: A Literature Review","volume":"12","author":"Hosseini","year":"2022","journal-title":"Adv. Pharm. Bull."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"ofaa016","DOI":"10.1093\/ofid\/ofaa016","article-title":"Hope on the Horizon: Novel Fungal Treatments in Development","volume":"7","author":"Rauseo","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Gintjee, T.J., Donnelley, M.A., and Thompson, G.R. (2020). Aspiring Antifungals: Review of Current Antifungal Pipeline Developments. J. Fungi, 6.","DOI":"10.3390\/jof6010028"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1126\/science.aap7999","article-title":"Worldwide emergence of resistance to antifungal drugs challenges human health and food security","volume":"360","author":"Fisher","year":"2018","journal-title":"Science"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Hsu, T.H., Huang, P.Y., Fan, Y.C., and Sun, P.L. (2022). Azole Resistance and cyp51A Mutation of Aspergillus fumigatus in a Tertiary Referral Hospital in Taiwan. J. Fungi, 8.","DOI":"10.3390\/jof8090908"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jhin.2021.03.003","article-title":"Risk assessment of arterial allograft contamination from tissue donors colonized by Candida auris","volume":"112","author":"Mirabet","year":"2021","journal-title":"J. Hosp. Infect."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jiph.2022.08.004","article-title":"Development and research progress of anti-drug resistant fungal drugs","volume":"15","author":"Cui","year":"2022","journal-title":"J. Infect. Public Health"},{"key":"ref_10","unstructured":"Gilbert, S.J., and Weiner, D.E. (2014). Kidney Disease Caused by Therapeutic Agents. National Kidney Foundation Primer on Kidney Diseases, W.B. Saunders. [6th ed.]."},{"key":"ref_11","first-page":"e130336","article-title":"Hepatotoxicity Induced by Azole Antifungal Agents: A Review Study","volume":"22","author":"Rakhshan","year":"2023","journal-title":"Iran. J. Pharm. Res. IJPR"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Croitoru, G.A., P\u00eervulescu, D.C., Niculescu, A.G., Epistatu, D., R\u0103dulescu, M., Grumezescu, A.M., and Nicolae, C.L. (2024). Nanomaterials in Immunology: Bridging Innovative Approaches in Immune Modulation, Diagnostics, and Therapy. J. Funct. Biomater., 15.","DOI":"10.3390\/jfb15080225"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Mobeen, H., Safdar, M., Fatima, A., Afzal, S., Zaman, H., and Mehdi, Z. (2022). Emerging applications of nanotechnology in context to immunology: A comprehensive review. Front. Bioeng. Biotechnol., 10.","DOI":"10.3389\/fbioe.2022.1024871"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Hussain, S. (2019). Immunization and Vaccination. Psychiatry of Pandemics: A Mental Health Response to Infection Outbreak, Springer.","DOI":"10.1007\/978-3-030-15346-5_13"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez-Ch\u00e1vez, M.J., P\u00e9rez-Garc\u00eda, L.A., Ni\u00f1o-Vega, G.A., and Mora-Montes, H.M. (2017). Fungal Strategies to Evade the Host Immune Recognition. J. Fungi, 3.","DOI":"10.3390\/jof3040051"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Scorzoni, L., de Paula ESilva, A.C., Marcos, C.M., Assato, P.A., de Melo, W.C., de Oliveira, H.C., Costa-Orlandi, C.B., Mendes-Giannini, M.J., and Fusco-Almeida, A.M. (2017). Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis. Front. Microbiol., 8.","DOI":"10.3389\/fmicb.2017.00036"},{"key":"ref_17","first-page":"005","article-title":"Development of Vaccination against Fungal Disease: A Review Article","volume":"1","author":"Tesfahuneygn","year":"2018","journal-title":"Int. J. Trop. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.4161\/hv.21838","article-title":"Universal fungal vaccines: Could there be light at the end of the tunnel?","volume":"8","author":"Hamad","year":"2012","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/09674845.2021.1907953","article-title":"Fungal vaccines","volume":"78","author":"Pattison","year":"2021","journal-title":"Br. J. Biomed. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41541-021-00294-8","article-title":"Vaccines for human fungal diseases: Close but still a long way to go","volume":"6","author":"Oliveira","year":"2021","journal-title":"npj Vaccines"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/cid\/ciy185","article-title":"A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis-A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial","volume":"66","author":"Edwards","year":"2018","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/s41385-022-00570-3","article-title":"Vaccine protection by Cryptococcus neoformans \u0394sgl1 is mediated by \u03b3\u03b4 T cells via TLR2 signaling","volume":"15","author":"Normile","year":"2022","journal-title":"Mucosal Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Singh, S., Nabeela, S., Barbarino, A., Ibrahim, A.S., and Uppuluri, P. (2022). Antibodies targeting Candida albicans Als3 and Hyr1 antigens protect neonatal mice from candidiasis. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2022.925821"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1146\/annurev-micro-041020-111511","article-title":"Harnessing the Immune Response to Fungal Pathogens for Vaccine Development","volume":"76","author":"Rivera","year":"2002","journal-title":"Annu. Rev. Microbiol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Song, J., Zhang, S., Xing, J., Zhang, L., Wang, J., and Shan, A. (2024). Optimizing therapeutic efficacy of antifungal peptides via strategic terminal amino acid modification. J. Adv. Res.","DOI":"10.1016\/j.jare.2024.09.017"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Ul Haq, I., Maryam, S., Shyntum, D.Y., Khan, T.A., and Li, F. (2024). Exploring the frontiers of therapeutic breadth of antifungal peptides: A new avenue in antifungal drugs. J. Ind. Microbiol. Biotechnol., 51.","DOI":"10.1093\/jimb\/kuae018"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Brady, D., Grapputo, A., Romoli, O., and Sandrelli, F. (2019). Insect Cecropins, Antimicrobial Peptides with Potential Therapeutic Applications. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20235862"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez de Ullivarri, M., Arbulu, S., Garcia-Gutierrez, E., and Cotter, P.D. (2020). Antifungal Peptides as Therapeutic Agents. Front. Cell. Infect. Microbiol., 10.","DOI":"10.3389\/fcimb.2020.00105"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1007\/s00018-011-0710-x","article-title":"Multifunctional cationic host defence peptides and their clinical applications","volume":"68","author":"Yeung","year":"2011","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.biochi.2016.05.013","article-title":"Antifungal peptides: To be or not to be membrane active","volume":"130","author":"Rautenbach","year":"2016","journal-title":"Biochimie"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Hsieh, I.N., and Hartshorn, K.L. (2016). The Role of Antimicrobial Peptides in Influenza Virus Infection and Their Potential as Antiviral and Immunomodulatory Therapy. Pharmaceuticals, 9.","DOI":"10.3390\/ph9030053"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Li, Z., Mao, R., Teng, D., Hao, Y., Chen, H., Wang, X., Wang, X., Yang, N., and Wang, J. (2017). Antibacterial and immunomodulatory activities of insect defensins-DLP2 and DLP4 against multidrug-resistant Staphylococcus aureus. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-10839-4"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1094\/PHYTO-09-18-0331-R","article-title":"Plant Defensin Peptides have Antifungal and Antibacterial Activity Against Human and Plant Pathogens","volume":"109","author":"Sathoff","year":"2019","journal-title":"Phytopathology"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Zolin, G.V.S., Fonseca, F.H.D., Zambom, C.R., and Garrido, S.S. (2021). Histatin 5 Metallopeptides and Their Potential against Candida albicans Pathogenicity and Drug Resistance. Biomolecules, 11.","DOI":"10.3390\/biom11081209"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Song, C., Wen, R., Zhou, J., Zeng, X., Kou, Z., Zhang, J., Wang, T., Chang, P., Lv, Y., and Wu, R. (2022). Antibacterial and Antifungal Properties of a Novel Antimicrobial Peptide GK-19 and Its Application in Skin and Soft Tissue Infections Induced by MRSA or Candida albicans. Pharmaceutics, 14.","DOI":"10.22541\/au.165115643.37740112\/v1"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.peptides.2015.07.023","article-title":"Antifungal activity of cathelicidin peptides against planktonic and biofilm cultures of Candida species isolated from vaginal infections","volume":"71","author":"Scarsini","year":"2015","journal-title":"Peptides"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.2147\/IJN.S93105","article-title":"Fungal diseases: Could nanostructured drug delivery systems be a novel paradigm for therapy?","volume":"11","author":"Voltan","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Kischkel, B., Rossi, S.A., Santos, S.R., Nosanchuk, J.D., Travassos, L.R., and Taborda, C.P. (2020). Therapies and Vaccines Based on Nanoparticles for the Treatment of Systemic Fungal Infections. Front. Cell. Infect. Microbiol., 10.","DOI":"10.3389\/fcimb.2020.00463"},{"key":"ref_39","first-page":"1","article-title":"Nanotechnology-Based Strategies for Combating Emerging and Re-emerging Fungal Infections","volume":"12","author":"Jahanshiri","year":"2024","journal-title":"J. Med. Microbiol. Infect. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpharm.2017.11.048","article-title":"Liposomes encapsulating native and cyclodextrin enclosed paclitaxel: Enhanced loading efficiency and its pharmacokinetic evaluation","volume":"536","author":"Bhatt","year":"2018","journal-title":"Int. J. Pharm."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.2147\/IJN.S160605","article-title":"In vivo antimicrobial activity of silver nanoparticles produced via a green chemistry synthesis using Acacia rigidula as a reducing and capping agent","volume":"13","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Sousa, F., Ferreira, D., Reis, S., and Costa, P. (2020). Current Insights on Antifungal Therapy: Novel Nanotechnology Approaches for Drug Delivery Systems and New Drugs from Natural Sources. Pharmaceuticals, 13.","DOI":"10.3390\/ph13090248"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"R50","DOI":"10.1111\/j.1750-3841.2009.01457.x","article-title":"Bioavailability and delivery of nutraceuticals using nanotechnology","volume":"75","author":"Huang","year":"2010","journal-title":"J. Food Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40265-013-0069-4","article-title":"Amphotericin B formulations: A comparative review of efficacy and toxicity","volume":"73","author":"Hamill","year":"2013","journal-title":"Drugs"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Hashem, A.H., Shehabeldine, A.M., Ali, O.M., and Salem, S.S. (2022). Synthesis of Chitosan-Based Gold Nanoparticles: Antimicrobial and Wound-Healing Activities. Polymers, 14.","DOI":"10.3390\/polym14112293"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Mi\u0161kovsk\u00e1, A., Rabochov\u00e1, M., Michailidu, J., Mas\u00e1k, J., \u010cejkov\u00e1, A., Lorin\u010d\u00edk, J., and Ma\u0165\u00e1tkov\u00e1, O. (2022). Antibiofilm activity of silver nanoparticles biosynthesized using viticultural waste. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0272844"},{"key":"ref_47","first-page":"165","article-title":"Antifungal activity of silver nanoparticles obtained by green synthesis","volume":"57","author":"Mallmann","year":"2015","journal-title":"Rev. Do Inst. De Med. Trop. De Sao Paulo"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.33263\/BRIAC101.902907","article-title":"A green deposition method of silver nanoparticles on textiles and their antifungal activity","volume":"10","author":"Fajar","year":"2019","journal-title":"Biointerface Res. Appl. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ijfoodmicro.2018.11.012","article-title":"Antifungal activity of silver nanoparticles and simvastatin against toxigenic species of Aspergillus","volume":"291","author":"Bocate","year":"2019","journal-title":"Int. J. Food Microbiol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Zhang, X.F., Liu, Z.G., Shen, W., and Gurunathan, S. (2016). Silver Nanoparticles: Synthesis, Characterization, Properties, Applications, and Therapeutic Approaches. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17091534"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"100794","DOI":"10.1016\/j.colcom.2024.100794","article-title":"Nanoparticle-based drug delivery systems: An updated strategy for treating fungal keratitis","volume":"61","author":"Guo","year":"2024","journal-title":"Colloid Interface Sci. Commun."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.3109\/10717544.2014.942811","article-title":"Enhanced corneal permeation and antimycotic activity of itraconazole against Candida albicans via a novel nanosystem vesicle","volume":"23","author":"Mohsen","year":"2016","journal-title":"Drug Deliv."},{"key":"ref_53","first-page":"161","article-title":"Ethosomes and ultradeformable liposomes for transdermal delivery of clotrimazole: A comparative assessment","volume":"20","author":"Maheshwari","year":"2012","journal-title":"Saudi Pharm. J. SPJ Off. Publ. Saudi Pharm. Soc."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1081\/DDC-54315","article-title":"Preparation, in vitro and in vivo evaluation of liposomal\/niosomal gel delivery systems for clotrimazole","volume":"31","author":"Ning","year":"2005","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Maftei, N.M., Raileanu, C.R., Balta, A.A., Ambrose, L., Boev, M., Marin, D.B., and Lisa, E.L. (2024). The Potential Impact of Probiotics on Human Health: An Update on Their Health-Promoting Properties. Microorganisms, 12.","DOI":"10.3390\/microorganisms12020234"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1111\/jam.15158","article-title":"Lactobacilli reduce recurrences of vaginal candidiasis in pregnant women: A randomized, double-blind, placebo-controlled study","volume":"132","author":"Ang","year":"2022","journal-title":"J. Appl. Microbiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s12602-016-9218-x","article-title":"Comparing the Recurrence of Vulvovaginal Candidiasis in Patients Undergoing Prophylactic Treatment with Probiotic and Placebo During the 6 Months","volume":"8","author":"Davar","year":"2016","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/myc.12883","article-title":"Randomised clinical trial in women with Recurrent Vulvovaginal Candidiasis: Efficacy of probiotics and lactoferrin as maintenance treatment","volume":"62","author":"Russo","year":"2019","journal-title":"Mycoses"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3920\/BM2022.0091","article-title":"Impact of Lactobacillus crispatus-containing oral and vaginal probiotics on vaginal health: A randomised double-blind placebo controlled clinical trial","volume":"14","author":"Smidt","year":"2023","journal-title":"Benef. Microbes"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e00458-19","DOI":"10.1128\/mSphere.00458-19","article-title":"Combined Antifungal Resistance and Biofilm Tolerance: The Global Threat of Candida auris","volume":"4","author":"Kean","year":"2019","journal-title":"mSphere"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1007\/s00253-016-7527-3","article-title":"Probiotic lactobacilli inhibit early stages of Candida albicans biofilm development by reducing their growth, cell adhesion, and filamentation","volume":"100","author":"Matsubara","year":"2016","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/1471-0528.15870","article-title":"Lactobacilli-containing vaginal probiotics to cure or prevent bacterial or fungal vaginal dysbiosis: A systematic review and recommendations for future trial designs","volume":"127","author":"Verwijs","year":"2020","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3920\/BM2019.0048","article-title":"Alleviation of vulvovaginitis symptoms: Can probiotics lead the treatment plan?","volume":"10","author":"Tsimaris","year":"2019","journal-title":"Benef. Microbes"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e12970","DOI":"10.1111\/dth.12970","article-title":"Probiotics for oral and vulvovaginal candidiasis: A review","volume":"32","author":"Shenoy","year":"2019","journal-title":"Dermatol. Ther."},{"key":"ref_65","first-page":"1","article-title":"Promising of Immunotherapy against Fungal","volume":"9","author":"Abate","year":"2023","journal-title":"Med. Mycol. Open Access"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s40588-020-00141-9","article-title":"Immunotherapy as an Antifungal Strategy in Immune Compromised Hosts","volume":"7","author":"Posch","year":"2020","journal-title":"Curr. Clin. Micro. Rpt."},{"key":"ref_67","first-page":"9870679","article-title":"Antifungal Resistance, Metabolic Routes as Drug Targets, and New Antifungal Agents: An Overview about Endemic Dimorphic Fungi","volume":"2017","author":"Amaral","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Taborda, C.P., and Nosanchuk, J.D. (2017). Editorial: Vaccines, Immunotherapy and New Antifungal Therapy against Fungi: Updates in the New Frontier. Front. Microbiol., 8.","DOI":"10.3389\/fmicb.2017.01743"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Davidson, L., Netea, M.G., and Kullberg, B.J. (2018). Patient Susceptibility to Candidiasis-A Potential for Adjunctive Immunotherapy. J. Fungi, 4.","DOI":"10.3390\/jof4010009"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1086\/499811","article-title":"Immunotherapy for fungal infections","volume":"42","author":"Segal","year":"2006","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Wurster, S., Watowich, S.S., and Kontoyiannis, D.P. (2022). Checkpoint inhibitors as immunotherapy for fungal infections: Promises, challenges, and unanswered questions. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1018202"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Sharma, J., Mudalagiriyappa, S., and Nanjappa, S.G. (2022). T cell responses to control fungal infection in an immunological memory lens. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.905867"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Ravikumar, S., Win, M.S., and Chai, L.Y. (2015). Optimizing Outcomes in Immunocompromised Hosts: Understanding the Role of Immunotherapy in Invasive Fungal Diseases. Front. Microbiol., 6.","DOI":"10.3389\/fmicb.2015.01322"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13225-023-00532-5","article-title":"Current trends, limitations and future research in the fungi","volume":"125","author":"Hyde","year":"2024","journal-title":"Fungal Divers."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Wijayawardene, N.N., Boonyuen, N., Ranaweera, C.B., de Zoysa, H.K.S., Padmathilake, R.E., Nifla, F., Dai, D.Q., Liu, Y., Suwannarach, N., and Kumla, J. (2023). OMICS and Other Advanced Technologies in Mycological Applications. J. Fungi, 9.","DOI":"10.3390\/jof9060688"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e01020-20","DOI":"10.1128\/mBio.01020-20","article-title":"Fun(gi)omics: Advanced and Diverse Technologies to Explore Emerging Fungal Pathogens and Define Mechanisms of Antifungal Resistance","volume":"11","author":"Ball","year":"2020","journal-title":"mBio"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Al Jindan, R., AlEraky, D.M., Farhat, M., Almandil, N.B., AbdulAzeez, S., and Borgio, J.F. (2023). Genomic Insights into Virulence Factors and Multi-Drug Resistance in Clostridium perfringens IRMC2505A. Toxins, 15.","DOI":"10.3390\/toxins15060359"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Champer, J., Ito, J.I., Clemons, K.V., Stevens, D.A., and Kalkum, M. (2016). Proteomic Analysis of Pathogenic Fungi Reveals Highly Expressed Conserved Cell Wall Proteins. J. Fungi, 2.","DOI":"10.3390\/jof2010006"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Li, G., Jian, T., Liu, X., Lv, Q., Zhang, G., and Ling, J. (2022). Application of Metabolomics in Fungal Research. Molecules, 27.","DOI":"10.3390\/molecules27217365"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Subramanian, I., Verma, S., Kumar, S., Jere, A., and Anamika, K. (2020). Multi-omics Data Integration, Interpretation, and Its Application. Bioinform. Biol. Insights, 14.","DOI":"10.1177\/1177932219899051"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1250684","DOI":"10.1126\/science.1250684","article-title":"mTOR- and HIF-1\u03b1-mediated aerobic glycolysis as metabolic basis for trained immunity","volume":"345","author":"Cheng","year":"2014","journal-title":"Science"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1251086","DOI":"10.1126\/science.1251086","article-title":"Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity","volume":"345","author":"Saeed","year":"2014","journal-title":"Science"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"de Jes\u00fas-Gil, C., Sans-de San Nicol\u00e0s, L., Ruiz-Romeu, E., Ferran, M., Soria-Mart\u00ednez, L., Garc\u00eda-Jim\u00e9nez, I., Chiriac, A., Casanova-Seuma, J.M., Fern\u00e1ndez-Armenteros, J.M., and Owens, S. (2021). Interplay between Humoral and CLA+ T Cell Response against Candida albicans in Psoriasis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22041519"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/infdis\/jiu607","article-title":"Multispecific Aspergillus T cells selected by CD137 or CD154 induce protective immune responses against the most relevant mold infections","volume":"211","author":"Stuehler","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Leit\u00e3o, J.H., and Rodr\u00edguez-Ortega, M.J. (2020). Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development. Vaccines, 8.","DOI":"10.3390\/vaccines8040653"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ccell.2022.09.011","article-title":"Technology meets TILs: Deciphering T cell function in the -omics era","volume":"41","author":"Hudson","year":"2023","journal-title":"Cancer Cell"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Dai, X., and Shen, L. (2022). Advances and Trends in Omics Technology Development. Front. Med., 9.","DOI":"10.3389\/fmed.2022.911861"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Bianconi, I., Aschbacher, R., and Pagani, E. (2023). Current Uses and Future Perspectives of Genomic Technologies in Clinical Microbiology. Antibiotics, 12.","DOI":"10.3390\/antibiotics12111580"}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/14\/2\/126\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:25:22Z","timestamp":1760027122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/14\/2\/126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,1]]},"references-count":88,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["pathogens14020126"],"URL":"https:\/\/doi.org\/10.3390\/pathogens14020126","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,1]]}}}